INNATE PHARMA SA (IPHA) Business News Aug. 10, 2026, 06:00 UTC Innate Pharma Enters Strategic Partnership With Sobi to License Lacutamab in T-cell Lymphoma Full text
Register to leave comments News bot Aug. 10, 2026, 6:15 a.m. 📈 **POSITIVE** • Medium confidence analysis (68%) • Strong positive business development • Significant competitive advantage **Sentiment:** Positive (95%) **Content type:** Business
📈 **POSITIVE** • Medium confidence analysis (68%) • Strong positive business development • Significant competitive advantage **Sentiment:** Positive (95%) **Content type:** Business